| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634588A1 Compositions and foods and drinks contiaing higher fatty acid derivative |
| 03/15/2006 | EP1633872A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/15/2006 | EP1633780A2 Control of lactation and peptides therefore |
| 03/15/2006 | EP1633306A2 Use of phosphatase inhibitors as adjunct therapy for psychiatric disorders |
| 03/15/2006 | EP1521595B1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1509530B1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/15/2006 | EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 03/15/2006 | EP1470155B1 Pluripotency determining factor and uses thereof |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1404303A4 Stable pharmaceutical compositions containing pravastatin |
| 03/15/2006 | EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups |
| 03/15/2006 | EP1383498B1 Crf receptor antagonists |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1331937B1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1322156B1 Disinfectant |
| 03/15/2006 | EP1309593B1 Substituted pyrazoles |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1296679B1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 03/15/2006 | EP1254209B1 Composition comprising hydroxycitric acid and garcinol for weight-loss |
| 03/15/2006 | EP1227085B1 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 03/15/2006 | EP1196172B1 (S,S)-Reboxetine for treating chronic pain |
| 03/15/2006 | EP1140044B1 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP1128842B1 Use of human protein c for the manufacture of a medicament for treating heparin-induced thrombocytopenia |
| 03/15/2006 | EP1068315B1 Therapeutic agent for ngf |
| 03/15/2006 | EP1001810B1 Pharmaceutical composition with neurotrophic-like biological activity |
| 03/15/2006 | EP0934292B1 Metalloproteinase inhibitors |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0870049B1 Complementary adenoviral vector systems and cell lines |
| 03/15/2006 | EP0733069B1 Purified primate ctla-8 antigens and related reagents |
| 03/15/2006 | CN1747744A Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 03/15/2006 | CN1747727A Inhibitor for perioperative blood sugar elevation |
| 03/15/2006 | CN1747711A Melanogenesis inhibitor and skin preparation containing the same |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1745804A Use of medicine containing Danshen Root inpreparing medicine against aspirin |
| 03/15/2006 | CN1745790A Chinese medicinal preparation for treating consumptive disease and its making method thereof |
| 03/15/2006 | CN1745780A Use of composition against aspirin |
| 03/15/2006 | CN1745767A Use of depot containing Chuanxiong against aspirin |
| 03/15/2006 | CN1745764A Use of depot containing safflower against aspirin |
| 03/15/2006 | CN1745761A Strengthening distillate |
| 03/15/2006 | CN1745757A Polypeptide bombycic powder and selenium-enriched male bombycic wine and their production |
| 03/15/2006 | CN1245417C Prodrugs of dipeptidyl peptidase IV inhibitors |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245404C Mercaptoacetylamide derivatives, process for their preparation and use thereof |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245400C N-substituted benzothiophenesulfonamide derivatives |
| 03/15/2006 | CN1245394C Substituted phenylacetamides and their use as glucokinase activators |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245389C Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245382C 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 03/15/2006 | CN1245220C New dressing material for promoting quick repair of surface of dermal wound |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245213C Microcapsule meterial for durative releasing two factors for restraining new-born blood vessels and its preparing method |
| 03/15/2006 | CN1245207C Modified technique for making zedoary turmeric oil and glucose injection |
| 03/15/2006 | CN1245167C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 03/15/2006 | CN1245164C Cell growth regulating factor oral liquid and its preparation process |
| 03/15/2006 | CN1245161C A method of modulating ion channel functional activity |
| 03/15/2006 | CN1245157C Novel fatty derivative for treatment of diabetes |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | US7012076 Quinazoline-4-sulfonamide derivatives |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/14/2006 | US7012066 for coadministration with interferon and antiviral agent |
| 03/14/2006 | US7012062 Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011951 Apoptosis-associated gene |
| 03/14/2006 | US7011851 Drug delivery; incontinence therapy |
| 03/14/2006 | US7011825 Erythropoietin solution preparation |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2357687C New pyridazine endothelin antagonists |
| 03/14/2006 | CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006026299A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | WO2006025567A1 Novel substituted imidazole derivatives |
| 03/09/2006 | WO2006025490A1 Molecular chaperone function regulator |
| 03/09/2006 | WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | WO2006025431A1 Antagonist against tolerance to anticancer drugs |
| 03/09/2006 | WO2006025324A1 Tropan compound |